FDA inspection
Livzon New North River Pharmaceutical Co., Ltd.: FDA inspection ending Dec 20, 2024
FDA inspection 1260618 · Voluntary Action Indicated (VAI) · Qingyuan
Key facts
| Inspection ID | 1260618 |
|---|---|
| Firm | Livzon New North River Pharmaceutical Co., Ltd. |
| FEI number | 3005619530 |
| Address | Renmin One Road |
| City | Qingyuan |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Dec 20, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data